Loading data for MRNA — first visit, this takes a few seconds.

알림

Moderna Inc. (MRNA)

NasdaqGS: MRNA · 실시간 가격 · USD

149.66

-9.17 (-5.77%)

종가 기준: Aug 26, 2026, 3:59 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

-5.77% (1D)

매수호가	140.22
시가총액	59.75B
매출 (ttm)	2.23B
순이익 (ttm)	-3.15B
	0.90
	-7.98
	n/a
	-32.47
P/B (ttm)	8.83
P/S (ttm)	26.82
실적 발표일	Nov 5, 2026

매도호가	156.24
거래량	21,836,510
평균 거래량 (20일)	13,898,833
시가	154.52
전일 종가	158.83
일중 범위	145.11 - 156.13
52주 범위	22.28 - 176.66
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

MRNA 소개

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zi...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Dec 7, 2018

직원 수 4,700

상장 거래소 NasdaqGS

티커 MRNA

웹사이트 https://www.modernatx.com

전체 기업 정보

재무 실적

2025년 Moderna의 매출은 1.92B로, 전년 3.2B 대비 -39.92% 감소했습니다. 순이익은 -2.82B로, -20.75% 감소했습니다.

재무제표

어닝 서프라이즈

Moderna가 Jul 31, 2026에 분기 실적을 발표했습니다:

매출 $143M 예상치 하회 $0, 및 4.38% 전년 대비 성장.
EPS -1.97 예상치 상회 0.09, 및 7.51% 전년 대비 성장.

다음 실적 발표

Moderna Inc.의 실적 발표 예정일은 Nov 5, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

16시간 전 · Barrons.com

Nvidia, Meta, Revolution Medicines, Abercrombie, Intuit, Salesforce, Moderna, and More Stocks That Explain Today’s Market

Stocks traded modestly lower Wednesday ahead of Nvidia’s earnings report and after the personal consumption expenditures index, or PCE, for July revealed inflation was a bit stronger than expected. I...

17시간 전 · Barrons.com

Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.

Daraxonrasib, the pill touted by a former member of Congress and cancer patient as a ‘miracle drug,’ has been granted approval in patients with pancreatic adenocarcinoma.

19시간 전 · Schaeffer's Investment Research

Novavax Stock Pulls Back After Milestone Vaccine Success

Novavax stock is garnering attention from options traders

20시간 전 · Barrons.com

Energy, Industrials, and Utilities Are Leading the Stock Market

With the market in a holding pattern ahead of Nvidia’s earnings report, industrials, energy, and utilities were doing the heavy lifting. The Dow Jones Industrial Average dropped 156 points, or 0.3%. T...

22시간 전 · 24/7 Wall St.

Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips

Moderna stock shed 7% on Wednesday with no company news to blame, reopening a brutal question that its 439% year-to-date rally had been drowning out: what exactly does a $59 billion valuation buy on a...

2 페이지 중 1